Saltar al contenido
Merck

Saltar a

1A01050

USP

6-Methyl-4-Phenylchromanol

Pharmaceutical Analytical Impurity (PAI)

Sinónimos:

(6-Methyl-4-phenylchroman-2-ol)

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
Talla/SKUDisponibilidadPrecio

Acerca de este artículo

Fórmula empírica (notación de Hill):
C16H16O2
Número CAS:
Peso molecular:
240.30
MDL number:
NACRES:
NA.24
UNSPSC Code:
41116107
eCl@ss:
25140904
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


grade

pharmaceutical analytical impurity (PAI)

agency

USP

manufacturer/tradename

USP

application(s)

pharmaceutical

format

neat

storage temp.

2-8°C

General description

Find answers to frequently asked questions on USP products in USP FAQs.
[6-Methyl-4-phenylchromanol (25 mg) (6-Methyl-4-phenylchroman-2-ol)] - CAS [209747-04-6] (usp.org)6-Methyl-4-Phenylchromanol is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Tolterodine tartrate.

Therapeutic Area: Renal.

For more information about this PAI, visit here.

Application

6-Methyl-4-Phenylchromanol (USP PAI) is intendedfor use in analytical testing to detect, identify, and measure pharmaceuticalimpurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
1A03210
description

Pharmaceutical Analytical Impurity (PAI)

description

Pharmaceutical Analytical Impurity (PAI)

manufacturer/tradename

USP

manufacturer/tradename

USP

grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical analytical impurity (PAI)

application(s)

pharmaceutical

application(s)

pharmaceutical

format

neat

format

neat

agency

USP

agency

USP

storage temp.

2-8°C

storage temp.

2-8°C


Clase de almacenamiento

11 - Combustible Solids

WGK

WGK 3

Punto de inflamación (°F)

Not applicable

Punto de inflamación (°C)

Not applicable



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Preguntas

Revisiones

Sin puntuación

Filtros activos